Assignee
SYNACT PHARMA APS
DK·2 granted patents·7 pending applications·2 citations·filing 2020–2025
Top patents by PatentIndex Score
9 records- 0181US12239631B2Polymorphs of phenyl pyrrole aminoguandium saltsSYNACT PHARMA APS·Filed 2024·Granted Mar 4, 2025·1 cites·27 claims
- 0273US12303489B2Combination treatment of arthritic diseaseSYNACT PHARMA APS·Filed 2020·Granted May 20, 2025·1 cites·18 claims
- 0369US2023114865A1Phenyl pyrrole aminoguanidine salts and formulationsSYNACT PHARMA APS·Filed 2022·Application pending·0 cites
- 0461US2023271922A9Polymorphs of phenyl pyrrole aminoguandium saltsSYNACT PHARMA APS·Filed 2022·Application pending·0 cites
- 0555US2025387365A1Combination Treatment Of Arthritic DiseaseSYNACT PHARMA APS·Filed 2025·Application pending·0 cites
- 0651US2025302804A1Resomelagon and its derivatives for the treatment of cardiovascular disease, hypertension and atherosclerosisSYNACT PHARMA APS·Filed 2023·Application pending·0 cites
- 0751US2025032449A1Treatment of rheumatoid arthritisSYNACT PHARMA APS·Filed 2022·Application pending·0 cites
- 0843US2023149351A1Treatment of symptomatic viral diseasesSYNACT PHARMA APS·Filed 2021·Application pending·0 cites
- 0943US2021121418A1Treatment of proteinuriaSYNACT PHARMA APS·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →